Literature DB >> 33387217

Long-term intradialytic hybrid exercise training on fatigue symptoms in patients receiving hemodialysis therapy.

Stefania S Grigoriou1, Argyro A Krase1, Christina Karatzaferi1, Christoforos D Giannaki2, Eleftherios Lavdas3, Georgia I Mitrou1, Saul Bloxham4, Ioannis Stefanidis5, Giorgos K Sakkas6,7.   

Abstract

PURPOSE: Hemodialysis (HD) patients suffer from generalized weakness, exercise intolerance and muscle atrophy, all leading to generalized fatigue and lack of energy. HD patients spend at least 50% of their time in a functionally "switch off" mode with their fatigue sensations reaching a peak in the immediate hours after the dialysis session. The purpose of the current study was to assess the effectiveness of a nine-month hybrid intradialytic exercise program on fatigue symptoms occurring during and after hemodialysis session.
METHODS: Twenty stable hemodialysis patients were included in the study (59 ± 13.7 years; 16 males). All patients completed a 9-month supervised exercise training program composed of both aerobic cycling and resistance training during HD. Aspects related to physical and generalized fatigue were assessed via validated questionnaires, while physical performance was assessed by a battery of tests, before and after the intervention period.
RESULTS: Exercise capacity and physical performance were increased by an average of 65 and 40%, respectively. Patients reported feeling better during post-dialysis hours in question 1 (p = 0.000), question 3 (p = 0.009) and question 4 (p = 0.003) after the 9-month intervention. In addition, exercise training improved scores in cognitive function (p = 0.037), vitality (p = 0.05), depression (p = 0.000) and fatigue (p = 0.039).
CONCLUSION: The present study showed that a 9-month hybrid (aerobic + resistance) exercise training program improved symptoms of post-dialysis fatigue and overall general perception of fatigue. Hybrid exercise training is a safe and effective non-pharmacological approach to ameliorate fatigue symptoms in HD patients. TRIAL REGISTRATION NUMBER: Trial registration number The study is registered at ClinicalTrials.gov (NCT01721551, 2012) as a clinical trial.

Entities:  

Keywords:  Aerobic; Anerobic; Cognition; Exercise; Post-dialysis fatigue; Quality of life

Year:  2021        PMID: 33387217     DOI: 10.1007/s11255-020-02711-8

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  48 in total

Review 1.  Fatigue in chronic dialysis patients.

Authors:  Maurizio Bossola; Carlo Vulpio; Luigi Tazza
Journal:  Semin Dial       Date:  2011-09-15       Impact factor: 3.455

Review 2.  Exercise in individuals with CKD.

Authors:  Kirsten L Johansen; Patricia Painter
Journal:  Am J Kidney Dis       Date:  2011-11-23       Impact factor: 8.860

3.  Neural and metabolic mechanisms of excessive muscle fatigue in maintenance hemodialysis patients.

Authors:  Kirsten L Johansen; Julie Doyle; Giorgos K Sakkas; Jane A Kent-Braun
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-05-19       Impact factor: 3.619

Review 4.  Society, mind and body in chronic fatigue syndrome: an anthropological view.

Authors:  N C Ware
Journal:  Ciba Found Symp       Date:  1993

5.  Quality of life in patients with bipolar I depression: data from 920 patients.

Authors:  Lakshmi N Yatham; Yves Lecrubier; Ronald R Fieve; Kimberly H Davis; Soyna D Harris; Anupama A Krishnan
Journal:  Bipolar Disord       Date:  2004-10       Impact factor: 6.744

6.  Haemodialysis patients with sleep apnoea syndrome experience increased central adiposity and altered muscular composition and functionality.

Authors:  Giorgos K Sakkas; Konstantinos I Gourgoulianis; Christina Karatzaferi; Vassilios Liakopoulos; Maria D Maridaki; Chaido Pastaka; Eleftherios Lavdas; Brian J Soher; Spiros Dovas; Ioannis Fezoulidis; Georgios M Hadjigeorgiou; Ioannis Stefanidis
Journal:  Nephrol Dial Transplant       Date:  2007-09-22       Impact factor: 5.992

Review 7.  Epidemiology, impact, and treatment options of restless legs syndrome in end-stage renal disease patients: an evidence-based review.

Authors:  Christoforos D Giannaki; Georgios M Hadjigeorgiou; Christina Karatzaferi; Marios C Pantzaris; Ioannis Stefanidis; Giorgos K Sakkas
Journal:  Kidney Int       Date:  2013-10-09       Impact factor: 10.612

8.  Hemodialysis fatigue: just "simple" fatigue or a syndrome on its own right?

Authors:  Giorgos K Sakkas; Christina Karatzaferi
Journal:  Front Physiol       Date:  2012-07-31       Impact factor: 4.566

9.  Evidence of increased muscle atrophy and impaired quality of life parameters in patients with uremic restless legs syndrome.

Authors:  Christoforos D Giannaki; Giorgos K Sakkas; Christina Karatzaferi; Georgios M Hadjigeorgiou; Eleftherios Lavdas; Vassilios Liakopoulos; Nikolaos Tsianas; Georgios N Koukoulis; Yiannis Koutedakis; Ioannis Stefanidis
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

10.  Restless legs syndrome is contributing to fatigue and low quality of life levels in hemodialysis patients.

Authors:  Christoforos D Giannaki; Michael Hadjigavriel; Akis Lazarou; Aristos Michael; Loukas Damianou; Efthimios Atmatzidis; Ioannis Stefanidis; Georgios M Hadjigeorgiou; Giorgos K Sakkas; Marios Pantzaris
Journal:  World J Nephrol       Date:  2017-09-06
View more
  2 in total

1.  The effect of a 9-month hybrid intradialytic exercise training program on nerve conduction velocity parameters in patients receiving hemodialysis therapy.

Authors:  Stefania S Grigoriou; Christina Karatzaferi; Christoforos D Giannaki; Gianna Patramani; Christina Vogiatzi; Georgia I Mitrou; Ioannis Stefanidis; Giorgos K Sakkas
Journal:  Int Urol Nephrol       Date:  2022-07-05       Impact factor: 2.370

2.  Effect of intradialytic exercise on geriatric issues in older patients undergoing hemodialysis: a single-center non-randomized controlled study.

Authors:  Hiroki Yabe; Kenichi Kono; Tomoya Yamaguchi; Naomi Yamada; Yumiko Ishikawa; Yoshiko Yamaguchi; Hisanori Azekura
Journal:  Int Urol Nephrol       Date:  2022-05-07       Impact factor: 2.266

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.